V., A.N. et al. 2024. OPTIMIZED SOLID LIPID NANOPARTICLES FOR ENHANCED ORAL BIOAVAILABILITY AND OSTEOGENIC EFFECT OF IPRIFLAVONE: FORMULATION, CHARACTERIZATION, AND IN VITRO EVALUATION. International Journal of Applied Pharmaceutics. 16, 6 (Nov. 2024), 79–89. DOI:https://doi.org/10.22159/ijap.2024v16i6.51890.